Lipids in high-risk patients presenting with ischemic stroke or transient ischemic attack: Are we missing the target?

Stroke

Volumn 45, Issue 11, 2014, Pages 3180-3181

  Goldstein, Larry B ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Editorials; Lipids; Prevention; Stroke

Indexed keywords

ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AMBULATORY CARE; BRAIN ISCHEMIA; CLINICAL PRACTICE; EDITORIAL; FOLLOW UP; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; LIPID BLOOD LEVEL; MEDICATION COMPLIANCE; PRIORITY JOURNAL; RISK FACTOR; STROKE PATIENT; TRANSIENT ISCHEMIC ATTACK; TREATMENT RESPONSE; BLOOD; CEREBROVASCULAR ACCIDENT; DYSLIPIDEMIA; FEMALE; MALE; PRACTICE GUIDELINE; STANDARDS;

BRAIN ISCHEMIA; CHOLESTEROL, LDL; DYSLIPIDEMIAS; FEMALE; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; STROKE;

EID: 84922480412     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.007436     Document Type: Editorial

References (14)

1. Ferreira-González I, Marsal JR, Mitjavila F, Parada A, Ribera A, Cascant P, et al. Patient registries of acute coronary syndrome: assessing or biasing the clinical real world data? Circ Cardiovasc Qual Outcomes. 2009;2:540-547.
2. Yeh RW, Kennedy K, Spertus JA, Parikh SA, Sakhuja R, Anderson HV, et al. Do postmarketing surveillance studies represent real-world populations? A comparison of patient characteristics and outcomes after carotid artery stenting. Circulation. 2011;123:1384-1390.
3. Saposnik G, Fonarow GC, Pan W, Liang L, Hernandez AF, Schwamm LH, et al. Guideline-directed low-density lipoprotein management in high-risk patients with ischemic stroke: findings from Get With The Guidelines-Stroke 2003 to 2012. Stroke. 2014:45:3343-3351.
4. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA. 2001;285:2486-2497.
5. De Caterina R, Scarano M, Marfisi R, Lucisano G, Palma F, Tatasciore A, et al. Cholesterol-lowering interventions and stroke. J Am Coll Cardiol. 2010;55:198-211.
6. Grundy SM, Cleeman JI, Merz CNB, Brewer HB, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation. 2004;110:227-239.
7. Wolf PA, Clagett PA, Easton JD, Goldstein LB, Gorelick PB, Kelly-Hayes M, et al. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack. Stroke. 1999;30:1991-1994.
8. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie KL, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. Stroke. 2006;37:577-617.
9. Webster F, Saposnik G, Kapral MK, Fang J, O'Callaghan C, Hachinski V. Organized outpatient care: stroke prevention clinic referrals are associated with reduced mortality after transient ischemic attack and ischemic stroke. Stroke. 2011;42:3176-3182.
10. McAlister FA, Majumdar SR, Padwal RS, Fradette M, Thompson A, Buck B, et al. Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. CMAJ. 2014;186:577-584.
11. White H, Boden-Albala B, Wang C, Elkind MS, Rundek T, Wright CB, et al. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: The Northern Manhattan Study. Circulation. 2005;111:1327-1331.
12. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-497.
13. Bushnell CD, Olson DM, Zhao X, Pan W, Zimmer LO, Goldstein LB, et al; AVAIL Investigators. Secondary preventive medication persistence and adherence 1 year after stroke. Neurology. 2011;77:1182-1190.
14. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 suppl 2):S1-S45.